Aspen Aerogels (NYSE:ASPN) reported a significant financial contraction for fiscal year 2025 on Wednesday, prompting the company to initiate a formal strategic review to optimize its cost structure and evaluate its asset portfolio.
The Northborough, Massachusetts-based technology leader saw its annual revenue plummet 40% to $271.1 million, compared to $452.7 million in 2024, as a "reset" in the U.S. electric vehicle (EV) market severely curtailed demand for its thermal barrier products.
The company’s bottom line was hit by a massive $389.6 million net loss, or approximately $(4.73) per share.
The results were dominated by a $291.2 million non-cash impairment charge, primarily related to the decision to suspend construction of its second aerogel manufacturing facility in Statesboro, Georgia.
Fourth-quarter performance underscored the depth of the slowdown, with revenue falling 66% year-over-year to $41.3 million.
Despite the top-line pressure, Aspen generated $16.1 million in operating cash flow during the quarter and successfully cut more than $75 million from its fixed cost base.
The company ended the year with $158.6 million in cash and equivalents.